Nabsys Nabsys to Take Another Shot at Commercializing Electronic Genome Mapping Technology Next Year Premium The Providence, Rhode Island-based firm plans to release its electronic genome mapping technology for human genome applications. Nabsys Raises Additional $13M From Hitachi High-Technologies Providence, Rhode Island-based Nabsys said the additional funding was a result of a technical milestone for its high-definition genome mapping platform. Nabsys Secures up to $38M in Equity Financing From Hitachi High-Tech The electronic genome mapping company said it will initially receive $25 million and can get an additional $13 million upon achieving certain milestones. Genome In a Bottle Consortium Releases Structural Variant Calling Benchmark Data Premium The public-private partnership has published a paper on a list of indels larger than 50 bp that is already being used to develop new methods. Nabsys Raises $21M in Round Led by Hitachi High-Technologies The company plans to use the funding to finish developing and commercially launch its HD-Mapping whole-genome electronic mapping platform. May 24, 2017 Nabsys Aims to Commercialize Genome Mapping Instrument Next Year Premium Oct 12, 2016 Nabsys Generates First Electronic Long-Range Human Genome Maps to Test Structural Variant Calling Premium Mar 31, 2016 Following Financial Restructuring, Nabsys Resurfaces With Much of Original Leadership Team Sep 14, 2015 Report: Nabsys Shuts Down Jan 20, 2015 Nabsys Using DNA Mapping Tech in 'Collaborative Mode'; Eyes Cancer Structural Variant Panels Premium Jan 12, 2015 Nabsys, Ariana Pharmaceuticals Collaborate to ID Structural Variants Linked to Cancer Nov 11, 2014 IP Roundup: NabSys, IMDx, Affymetrix, and Illumina Win US Patents Premium Nov 4, 2014 With New Management, Nabsys Shifts Focus to Cancer Structural Variation Analysis Premium Oct 29, 2014 People in the News: Jeffrey Leiden, Anthony Shuber Premium Oct 28, 2014 Paired Ends: Anthony Shuber, Greg Lucier, Craig Tuttle Premium Oct 14, 2014 IP Roundup: Affymetrix, Nabsys, Ohio State U, Fujirebio Win US Patents Premium Feb 25, 2014 Nabsys to Commercialize Electronic DNA Mapping Platform in 2014; Shows Data at AGBT Premium Mar 13, 2013 Nabsys Raises $20M in Private Financing Round Jan 15, 2013 Nabsys to Launch First Version of Sequencing System this Year for Genome Mapping Applications Premium Jan 17, 2012 Nabsys Develops 'Positional Sequencing' Tech for Assembly, Whole-Genome Mapping, Targeted Sequencing Premium Jan 10, 2012 Nabsys Prepares to Commercialize Nanodetector 'Positional Sequencing' Tech Premium Jan 10, 2012 Paired Ends: Marc Stapley, Stan Rose, Michael Hunkapiller, Jeffrey Sklar, Martin Tolar Premium Jan 3, 2012 Desktop Sequencers Take Center Stage in 2011 as Platform Providers Face Tough Times Premium Sep 20, 2011 Nabsys Raises $10M for Development of its Semiconductor-Based Sequencing System Premium Sep 14, 2011 Sequencing Technology Firm Nabsys Raises $10M in Series C Round Load More Breaking News Simple HealthKit Raises $8M in Series A Round Top Five Articles on GenomeWeb Last Week: Quantum-Si Layoffs, UBS Coverage Initiations, More LumiraDx Secures FDA Emergency Use Authorization, UK Approval for COVID-19, Flu Test Rarity Bioscience Raises Additional €500,000 Cancer Prognoses Informed by Module-Based Approach, Study Finds The Scan UK Team Presents Genetic, Epigenetic Sequencing Method Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers. DNA Biobank Developed for French Kidney Donors, Recipients The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France. Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site. Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.